We are live on
!
Find out more
Brown Advisory Portfolio holdings
AUM
$60.9B
1-Year Est. Return
15.24%
This Fund
S&P 500
This Quarter
Est. Return
+5.81%
1 Year Est. Return
+15.24%
3 Year Est. Return
+71.23%
5 Year Est. Return
+86.65%
10 Year Est. Return
+447.92%
AUM
$32.7B
AUM Growth
+$3.39B
(+12%)
Cap. Flow
+$2.02B
Cap. Flow
% of AUM
6.18%
Top 10 Holdings %
Top 10 Hldgs %
20.34%
Holding
1,273
New
114
Increased
570
Reduced
394
Closed
56
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoetis
ZTS
|
+$437M |
| 2 |
Intuit
INTU
|
+$333M |
| 3 |
Mastercard
MA
|
+$203M |
| 4 |
Booking.com
BKNG
|
+$186M |
| 5 |
Alibaba
BABA
|
+$155M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$290M |
| 2 |
Akamai
AKAM
|
+$278M |
| 3 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$264M |
| 4 |
Cognizant
CTSH
|
+$252M |
| 5 |
Acuity Brands
AYI
|
+$233M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.14% |
| 2 | Financials | 16.99% |
| 3 | Healthcare | 14.67% |
| 4 | Consumer Discretionary | 12.2% |
| 5 | Communication Services | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Estee Lauder
EL
$29.9B
| $392M | 1.2% |
4,084,209
-362,590
| -8% | -$33.3M |
|
27
Berkshire Hathaway Class B
BRK.B
$1.06T
| $379M | 1.16% |
2,237,127
+503,878
| +29% | +$83.8M |
|
|
28
Intuit
INTU
$81B
| $369M | 1.13% |
2,775,647
+2,564,515
| +1,215% | +$333M |
|
29
Wells Fargo
WFC
$263B
| $360M | 1.1% |
6,500,025
+1,586,434
| +32% | +$85M |
|
30
Genpact
G
$5.2B
| $344M | 1.05% |
12,351,102
-348,653
| -3% | -$9.04M |
|
31
Wabtec
WAB
$49.7B
| $334M | 1.02% |
3,645,319
-449,718
| -11% | -$37.5M |
|
32
Starbucks
SBUX
$120B
| $317M | 0.97% |
5,442,402
+45,326
| +0.8% | +$2.74M |
|
33
JPMorgan Chase
JPM
$918B
| $309M | 0.94% |
3,380,279
+542,666
| +19% | +$46.8M |
|
34
A.O. Smith
AOS
$8.17B
| $305M | 0.93% |
5,416,630
+133,799
| +3% | +$7.22M |
|
|
SCHW
35
Charles Schwab
SCHW
$174B
| $303M | 0.93% |
7,057,309
+1,922,591
| +37% | +$77M |
|
36
Corpay
CPAY
$24B
| $298M | 0.91% |
2,064,559
-74,774
| -3% | -$10.7M |
|
|
ANSS
37
DELISTED
Ansys
ANSS
| $284M | 0.87% |
2,337,022
+312,272
| +15% | +$36.8M |
|
38
ExxonMobil
XOM
$637B
| $282M | 0.86% |
3,487,634
+665,692
| +24% | +$54.5M |
|
39
Lowe's Companies
LOW
$115B
| $254M | 0.78% |
3,277,440
+840,197
| +34% | +$68.7M |
|
40
Walt Disney
DIS
$169B
| $254M | 0.78% |
2,388,690
+893,921
| +60% | +$97.9M |
|
41
TripAdvisor
TRIP
$1.59B
| $235M | 0.72% |
6,149,430
-796,571
| -11% | -$32.9M |
|
42
CarMax
KMX
$8.36B
| $233M | 0.71% |
3,697,885
+822,211
| +29% | +$49.7M |
|
43
Accenture
ACN
$86.9B
| $221M | 0.68% |
1,787,689
+591,726
| +49% | +$72.1M |
|
44
Canadian National Railway
CNI
$77.9B
| $219M | 0.67% |
2,697,200
+1,087,034
| +68% | +$82.9M |
|
45
iShares Core S&P 500 ETF
IVV
$887B
| $208M | 0.64% |
856,502
+82,467
| +11% | +$19.9M |
|
46
Johnson & Johnson
JNJ
$610B
| $200M | 0.61% |
1,511,313
+150,029
| +11% | +$19.1M |
|
47
DexCom
DXCM
$28.4B
| $194M | 0.59% |
10,601,552
-342,016
| -3% | -$6.32M |
|
|
48
Alibaba
BABA
$279B
| $184M | 0.56% |
1,306,649
+1,258,518
| +2,615% | +$155M |
|
49
Elevance Health
ELV
$85.6B
| $182M | 0.56% |
966,357
+482,868
| +100% | +$86.8M |
|
50
Kinder Morgan
KMI
$72.2B
| $175M | 0.54% |
9,151,974
+1,765,831
| +24% | +$35.1M |
|
Similar funds
QCM
Brown Advisory's Q2 2017 Portfolio in Review
As of Q2 2017, Brown Advisory held 1,273 positions worth $32.7B, up 12% from $29.3B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Brown Advisory deployed $2.02B of net new capital in Q2 2017, opening 114 new positions and adding to 570 existing holdings. Its largest new stake was Altaba Inc: 2,311,186 shares worth $126M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Alexion Pharmaceuticals, an estimated $290M trimmed.
- Brown Advisory's largest Q2 2017 buy was Altaba Inc: 2,311,186 shares worth $126M.
- Brown Advisory added most to Zoetis in Q2 2017, an estimated $437M increase.
- Brown Advisory's biggest Q2 2017 reduction was Alexion Pharmaceuticals, cutting an estimated $290M.
- Brown Advisory fully exited Mead Johnson Nutrition Company in Q2 2017, selling an estimated $264M.
- Brown Advisory's ten largest holdings make up 20% of its $32.7B portfolio in Q2 2017.
- Brown Advisory opened 114 new positions and closed 56 in Q2 2017.
- Brown Advisory's portfolio value rose 12% quarter-over-quarter to $32.7B.
Based on Brown Advisory's 13F filing for Q2 2017, filed 14 Aug 2017.